Nasser Aljasser

Drug Safety and Risk Management Department, Pharmacovigilance Executive Directorate, Saudi Food and Drug Authority (SFDA), Riyadh, Saudi Arabia

Presentation(s):

• SP04B - Awareness of Isotretinoin Use and Saudi FDA Pregnancy Prevention Program in Riyadh, Saudi Arabia: A Cross-sectional Study Among Female Patients

  Tuesday, August 24, 2021
  3:30 PM – 4:45 PM US Eastern Time

• SP04G - Dermatologists Awareness and Compliance with Saudi FDA Isotretinoin Pregnancy Prevention Program in Saudi Arabia: A Cross-sectional Study

  Tuesday, August 24, 2021
  3:30 PM – 4:45 PM US Eastern Time